Home
About
Overview
Sharing Data
ORCID
Help
History (37)
Runx2-Smad signaling impacts the progression of tumor-induced bone disease.
Single-institution experience with pemetrexed and bevacizumab as salvage therapy in advanced non-small-cell lung cancer.
Obesity and its association to phenotype and clinical course in hypertrophic cardiomyopathy.
Inhibition of dendritic spine morphogenesis and synaptic transmission by activity-inducible protein Homer1a.
Reviewing concomitant medications for participants in oncology clinical trials.
See All 37 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Reviewing concomitant medications for participants in oncology clinical trials.
McGahey KE, Weiss GJ. Reviewing concomitant medications for participants in oncology clinical trials. Am J Health Syst Pharm. 2017 Apr 15; 74(8):580-586.
View in:
PubMed
subject areas
Adult
Antineoplastic Agents
Clinical Trials as Topic
Drug Interactions
Drugs, Investigational
Humans
Neoplasms
Practice Guidelines as Topic
authors with profiles
Glen Weiss MD, MBA